Compare PLRX & KG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLRX | KG |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 87.3M |
| IPO Year | 2020 | 2025 |
| Metric | PLRX | KG |
|---|---|---|
| Price | $1.15 | $6.27 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.67 | N/A |
| AVG Volume (30 Days) | ★ 423.4K | 38.4K |
| Earning Date | 05-06-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.97 | ★ 1819.15 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $34,049,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 785.08 |
| 52 Week Low | $1.02 | $6.24 |
| 52 Week High | $1.95 | $29.13 |
| Indicator | PLRX | KG |
|---|---|---|
| Relative Strength Index (RSI) | 56.81 | 36.15 |
| Support Level | $1.12 | N/A |
| Resistance Level | $1.19 | $8.23 |
| Average True Range (ATR) | 0.04 | 0.58 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 71.91 | 15.93 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Kestrel Group Ltd specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers with two reportable segments: Program Services and Legacy Reinsurance. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.